Active Non-Segmental Vitiligo

(Oral Therapy) Janus kinase JAK3 inhibitor; Tyrosine kinase TYK2 / JAK1 inhibitor; Placebo

(PF-06651600 or PF-06700841)

Do you meet the requirements?

  • Male or female, age 18 to 65 years at time of consent
  • Have a clinical diagnosis of non-segmental vitiligo for at least 3 months
  • Body surface area (BSA)  involvement 4%-50% excluding involvement at palms of the hands, dorsal aspect of the fingers and thumbs including metacarpophalangeal joints, soles of feet, or dorsal aspect of the feet19 visits during a 60 week period: Travel reimbursement TBD

The Derm Group Location: Verona, NJ

For more information, call 1-(973)571-2121 ext. 5920 or email ctrials@thedermgroup.com

Or Contact The Verona Research Hotline 1-201-478-9119 Call or Text

Back to Top